Skip to main content
Caplight Logo









OculoMotor Technologies

OculoMotor Technologies

Private
Newark, New JerseyHealthcare & Life Scienceshttps://oculomotortechnologies.com

Last Round

Grant

May 1, 2021

Total Funding Raised

$1.88M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OculoMotor Technologies is a medical device company that develops virtual reality-based vision therapy platforms for the diagnosis and treatment of binocular vision disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, AR/VR Experiences, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

VR vision therapyeye trackingconvergence insufficiencydigital therapeuticsDTxmedical VRvision diagnosticsvision rehabilitationbinocular vision disordersoculomotor testinggamified therapyFDA cleared medical deviceoptometry toolsmedtechHIPAA compliant softwareconcussion vision therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OculoMotor Technologies Comparables

Compare OculoMotor Technologies with similar companies based on industry and business-model similarity.

OculoMotor Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivid Vision
89%
Luminopia, Inc.
83%
RightEye
81%

OculoMotor Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2021
SeedJul 11, 2019
GrantJun 24, 2019
GrantOct 9, 2018
GrantOct 13, 2017

Key People

Founding team and executive leadership

Vinay Chandorkar

Chief Operating Officer

Executive Team

OculoMotor Technologies Investors

Notable investors and investment history

OculoMotor Technologies investors
InvestorRounds
Foundation Venture Capital GroupSeed
New Jersey Health FoundationGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 70% MoM.

  • May 1, 2021

    $1M grant from the National Science Foundation.

OculoMotor Technologies Filings

Explore SEC and related filing metadata, where available.

OculoMotor Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OculoMotor Technologies's valuation, stock price, and market status.

Is OculoMotor Technologies a public or private company?

OculoMotor Technologies is a private company.

What is the current stock price of OculoMotor Technologies?

OculoMotor Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is OculoMotor Technologies worth (valuation)?

Valuation information for OculoMotor Technologies is not publicly available.

Can I buy OculoMotor Technologies stock?

OculoMotor Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OculoMotor Technologies's last funding round?

OculoMotor Technologies's most recent funding round was Grant on April 30, 2021.

Who are the main investors in OculoMotor Technologies?

Key investors in OculoMotor Technologies include Foundation Venture Capital Group.

Will OculoMotor Technologies IPO soon?

No public IPO plans have been announced for OculoMotor Technologies.

How can I track OculoMotor Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OculoMotor Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewark, New Jersey
Employee Range4
Year Founded2018
Last FundingMay 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?